This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Glaxosmithkline LLC. Active years: 2011-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2014
Title: Innovations of Jesus Raul Medina
Introduction
Jesus Raul Medina is an accomplished inventor based in Collegeville, PA (US). He has made significant contributions to the field of chemical compounds and pharmaceutical compositions. With a total of 2 patents, his work focuses on developing innovative solutions for various medical conditions.
Latest Patents
One of his latest patents involves chemical compounds, specifically 6-(4-pyrimidinyl)-1H-indazole derivatives. This invention is directed towards compounds that act as inhibitors of PDK1, which can be beneficial in treating immune and metabolic diseases, particularly cancers of the breast, colon, and lung. Additionally, he has developed pharmaceutical compositions that incorporate these compounds, along with methods for inhibiting PDK1 activity.
Another notable patent by Medina pertains to peptide deformylase inhibitors. This invention introduces novel PDF inhibitors and outlines innovative methods for their application in medical treatments.
Career Highlights
Jesus Raul Medina is currently associated with GlaxoSmithKline LLC, where he continues to advance his research and development efforts. His work has the potential to impact the treatment of various diseases significantly.
Collaborations
Throughout his career, Medina has collaborated with notable colleagues, including Jeffrey Michael Axten and Charles William Blackledge, Jr. These partnerships have contributed to the success of his innovative projects.
Conclusion
In summary, Jesus Raul Medina is a prominent inventor whose work in chemical compounds and pharmaceutical compositions is paving the way for advancements in medical treatments. His contributions are vital in addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
